Garraway L, Widlund H, Rubin M, Getz G, Berger A, Ramaswamy S, Beroukhim R, Milner D, Granter S, Du J, et al. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature. 2005;436(7047):117–22.

Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin A, Kim S, Wilson C, Lehár J, Kryukov G, Sonkin D, et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 2012;483(7391):603–7.

Cancer Cell Line Encyclopedia Consortium, Genomics of Drug Sensitivity in Cancer Consortium. Pharmacogenomic agreement between two cancer cell line data sets. Nature. 2015;528(7580):84–7.

Nusinow D, Szpyt J, Ghandi M, Rose C, McDonald R, Kalocsay M, Jané-Valbuena J, Gelfand E, Schweppe D, Jedrychowski M, et al. Quantitative Proteomics of the Cancer Cell Line Encyclopedia. Cell. 2020;180(2):387–402.e16.

Solit D, Garraway L, Pratilas C, Sawai A, Getz G, Basso A, Ye Q, Lobo J, She Y, Osman I, et al. BRAF mutation predicts sensitivity to MEK inhibition. Nature. 2006;439(7074):358–62.

Jaffe J, Wang Y, Chan HM, Zhang J, Huether R, Kryukov G, Bhang H- eun, Taylor J, Hu M, Englund N, et al. Global chromatin profiling reveals NSD2 mutations in pediatric acute lymphoblastic leukemia. Nat Genet. 2013;45(11):1386–91.

Ghandi M, Huang F, Jané-Valbuena J, Kryukov G, Lo C, McDonald R, Barretina J, Gelfand E, Bielski C, Li H, et al. Next-generation characterization of the Cancer Cell Line Encyclopedia. Nature. 2019;569(7757):503–508.

Li H, Ning S, Ghandi M, Kryukov G, Gopal S, Deik A, Souza A, Pierce K, Keskula P, Hernandez D, et al. The landscape of cancer cell line metabolism. Nat Med. 2019;25(5):850–860.